Form 4: Merit Medical Systems CEO Fred Lampropoulos Sells Shares

Sentiment:

SEC Form 4 Filing


Fred Lampropoulos, President and CEO of Merit Medical Systems, sold a significant number of shares on March 5, 2025, according to a Form 4 filing with the SEC.

Summary

  • On March 5, 2025, Fred Lampropoulos, the President and CEO of Merit Medical Systems, executed multiple sales of common stock.
  • He sold 11,320 shares at a weighted average price of $104.05, 20,000 shares at a weighted average price of $103.75, 409.741 shares at $103.75, and 2,590.001 shares at $103.75.
  • Following these transactions, Lampropoulos directly owns 1,086,028 shares of Merit Medical Systems common stock.
  • He also indirectly owns 97,798 shares through a 401(k) plan, 90 shares as custodian for a child, and 10,324.259 shares and 7,734.258 shares through his spouse.
  • Lampropoulos also holds non-qualified stock options to purchase shares of common stock at various exercise prices and expiration dates.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock sales by an executive, which doesn't inherently convey positive or negative sentiment. It's a factual report of transactions.

Industry Context

Executive stock sales are a common occurrence and are often scrutinized by investors for insights into a company's prospects; however, they don't always indicate a negative outlook.

Stakeholder Impact

  • Shareholders may react to the news of the CEO's stock sale, potentially impacting the stock price.
  • The sale could be perceived as a lack of confidence in the company's future performance, although it could also be for personal financial reasons.

Key Dates

DateDescription
03/01/2020Date from which non-qualified stock options become exercisable in installments.
06/22/2020Date options not vested were forfeited.
02/26/2021Date from which non-qualified stock options become exercisable in installments.
03/19/2022Date from which non-qualified stock options become exercisable in installments.
02/28/2024Date from which non-qualified stock options become exercisable in installments.
02/28/2025Date of plan holdings for 401(k).
03/05/2025Date of the stock sale transactions.
03/06/2025Date of the Form 4 filing.
03/01/2026Expiration date for some non-qualified stock options.
02/26/2027Expiration date for some non-qualified stock options.
03/19/2028Expiration date for some non-qualified stock options.
02/28/2030Expiration date for some non-qualified stock options.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.